Inhalation Sciences Sweden AB

Inhalation research instruments and CRO services for preclinical pharma/biotech development.

ISAB | SPGR

Overview

Corporate Details

ISIN(s):: SE0009983893 (+2 more)
LEI:: 54930018BAFIJ0IXTL75
Country:: Sweden
Address:: C/O Kliniskt Forskningscentrum KFC, 141 57 Huddinge
Website:: https://www.inhalation.se/
Sector:: Professional, scientific and technical activities
Industry:: Research and experimental development on natural sciences and engineering

Description

Inhalation Sciences Sweden AB is a life sciences company specializing in inhalation research. The company develops and sells patented laboratory instruments and provides contract research organization (CRO) services. Its flagship technology, the PreciseInhale® platform, offers precise aerosol generation and exposure control, enabling detailed studies on how inhaled particles affect the respiratory system. This system provides high-quality data on dose-response relationships and regional lung deposition. Through its Inhalation Research Services, the company supports pharmaceutical and biotech clients in the preclinical development of orally inhaled and intra-nasal drug products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Inhalation Sciences Sweden AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Inhalation Sciences Sweden AB via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
OPTIBIOTIX HEALTH PLC Develops microbiome-modulating ingredients and supplements to manage chronic lifestyle diseases.	United Kingdom	OPTI
OXFORD BIODYNAMICS PLC Develops precision blood tests using 3D genomics for cancer diagnosis and therapy guidance.	United Kingdom	OBD
Pharnext	France	ALPHA
PHYSIOMICS PLC De-risks oncology drug development for pharma/biotech using modeling and simulation.	United Kingdom	PYC
PILA PHARMA AB Clinical-stage biopharma developing a first-in-class oral drug for diabetes and obesity.	Sweden	PILA
POOLBEG PHARMA PLC AI-led biopharma developing drugs for high-need diseases like CRS and metabolic disorders.	United Kingdom	POLB
PROTEOME SCIENCES PLC CRO providing proteomics services & TMT® tags to biopharma for drug discovery & biomarkers.	United Kingdom	PRM
PROVEXIS PLC Develops & licenses Fruitflow®, a patented ingredient for heart health in food & supplements.	United Kingdom	PXS
Quantum Base Holdings PLC Develops uncopiable atomic fingerprints for anti-counterfeiting, verifiable by smartphone.	United Kingdom	N/A
QUANTUM BLOCKCHAIN TECHNOLOGIES PLC R&D firm using AI and quantum computing to create efficient technologies for Bitcoin mining.	United Kingdom	QBT